🔴 Senti Biosciences is trading 7.8% down

Senti Biosciences is trading at $0.24, down 7.84%, with no specific catalyst established for the decline.

• Shareholders approved the merger and a discretionary 1-for-20 to 1-for-50 reverse split on October 15; reports do not establish that approval caused the October 16 decline.
• An October 15 after-hours rally was reported, but does not explain the subsequent move.
• Biotech sector strength offers no clear explanation; no specific company, sector, or market catalyst is established.